Limited activity: This researcher has not published recently (last publication: 2017). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2017
Sources OpenAlex · ORCID
Refreshed 2026-08-08

LF Hutchins

Researcher

Also affiliated: Winthrop Rockefeller Foundation (2017)

Unknown Researcher

3 h-index 6 pubs 34 cited

  • Humans
  • Acute Disease
  • Agammaglobulinemia
  • Aged
  • Celiac Disease
  • Chronic Disease
  • Leukemia, Lymphoid
  • Male
  • Severity of Illness Index
  • Breast Neoplasms
  • Cell Division
  • Combined Modality Therapy
  • Estradiol
  • Female
  • Flow Cytometry

Biography and Research Information

OverviewAI-generated summary

LF Hutchins' research has focused on understanding the molecular mechanisms underlying various disease processes. Their work has investigated the role of specific cellular pathways and genetic factors in the progression of conditions such as cancer and metabolic disorders. Hutchins has also explored the pharmacological aspects of disease treatment, including drug efficacy and potential toxicities. Their publications indicate a recent focus on cancer-related molecular mechanisms and the study of metabolic pathways.

Metrics

  • h-index: 3
  • Publications: 6
  • Citations: 34

Selected Publications

  • Abstract P6-10-06: Inducing immune responses to tumor associated carbohydrate antigens by a carbohydrate mimetic peptide vaccine: Clinical experience in phase I and phase II trials (2017)
    Cancer Research 1 citation DOI OpenAlex
  • Abstract P5-11-19: Sexual functioning among breast cancer survivors and their partners: A pilot study (2017)
    Cancer Research DOI OpenAlex
  • Celiac crisis in a patient with chronic lymphocytic leukemia and hypogammaglobulinemia (2010)
    Clinics and Research in Hepatology and Gastroenterology 7 citations DOI OpenAlex
  • Venous thromboembolism (VTE) and erythropoiesis-stimulating agents (ESAs) in breast cancer: a single tertiary care center experience from the University of Arkansas for Medical Sciences (UAMS). (2009)
    Cancer Research DOI OpenAlex
  • Bevacizumab combined with chemotherapy significantly improves pathologic complete response in patients with operable or locally advanced breast cancer. (2009)
    Cancer Research 8 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics